Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Artelo Biosciences Inc market cap is $1.3M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Artelo Biosciences Inc 52 week high is $179.19 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Artelo Biosciences Inc 52 week low is $1.30 as of November 22, 2026.
Artelo Biosciences Inc stock price today is $1.39.
Artelo Biosciences Inc stock price yesterday was $1.45.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Artelo Biosciences Inc's P/E ratio is -0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Artelo Biosciences Inc P/B ratio is 0.2089.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Artelo Biosciences Inc 50-day moving average is $3.04.